Hormones May Protect Ovaries, Preserve Fertility in Breast Cancer
September 29th 2015Chemotherapy in young women can damage ovaries and result in premature menopause, but new research shows that the addition of hormonal treatment may preserve ovarian function and fertility in patients with breast cancer and may increase the chances of pregnancy after treatment.
Genomic Profiling Study Brings Personalized Medicine to Metastatic Bladder Cancer Patients
September 24th 2015The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder cancer study. The Hoosier Cancer Research Network (HCRN) will act as the coordinating center.
Diet With Extra Olive Oil May Lower Risk of Breast Cancer
September 17th 2015A study to test the effects of the Mediterranean diet on the prevention of cardiovascular disease yielded an unexpected result-the Mediterranean diet supplemented with extra virgin olive oil (EVOO) lowered the risk of breast cancer in older women by 68%.
Optimism Aplenty as Patients and Survivors Celebrate Life & Liberty
September 15th 2015The day after the 14th anniversary of the September 11 terrorist attacks, Richard Funcheon gazed at One World Trade Center along New York City's skyline as he stood in line at Liberty State Park waiting to get his caricature drawn.
Acupuncture Abates Hot Flashes in Breast Cancer Survivors
September 14th 2015Hot flashes are severe, daily nuisances for many breast cancer survivors, but a few needle pricks from acupuncture may be enough to cool the unpleasant episodes, according to a new study published in the Journal of Clinical Oncology.
FDA to Review Uridine Triacetate as Antidote to Serious 5-FU Toxicity
September 10th 2015The FDA will review a new drug application for the oral agent uridine triacetate as a treatment for patients at risk of serious toxicity following an overdose of 5-fluorouracil (5-FU) or are exhibiting symptoms of serious toxicity within 96 hours of 5-FU administration.
Most Young Lung Cancer Patients Have Actionable Mutations
September 9th 2015A preliminary analysis of an ongoing study shows that most patients diagnosed with lung cancer before age 40 had an increased chance for a targeted genomic alteration, knowledge of which could lead to more effective, targeted treatment.